Medication Evaluation in Portuguese Elderly Patients According to Beers, STOPP/START Criteria and EU(7)-PIM List – An Exploratory Study

References

• Laroche M, Charmes J, Nouaille Y, Picard N, Merle L. Is inappropriate medication use a major cause of adverse drug reactions in the elderly? Br J Clin Pharmacol. 2006;63(2):177–186. doi:10.1111/j.1365-2125.2006.02831.x
   Web of Science ®Google Scholar
• O´Connor MN, Gallagher P, O´Mahony D. Inappropriate prescribing. Criteria, detection and prevention. Drugs Aging. 2012;29(6):437–452. doi:10.2165/11632610-000000000-00000
   Web of Science ®Google Scholar
• Gallagher P, Baeyens J, Topinkova E, et al. Inter-rater reliability of STOPP (Screening Tool of Older Persons ’ Prescriptions) and START (Screening Tool to Alert doctors to Right Treatment) criteria amongst physicians in six European countries. Age Ageing. 2009:603–606. doi:10.1093/ageing/afp097.
   Web of Science ®Google Scholar
• Klarin I, Wimo A, Fastbom J. The association of inappropriate drug use with hospitalisation and mortality. Drugs Aging. 2005;22(1):69–82. doi:10.2165/00002512-200522010-00005
   PubMed Web of Science ®Google Scholar
• Onder G, Liperoti R, Fialova D, et al. Polypharmacy in nursing home in Europe: results from the SHELTER study. J Gerontol a Biol Sci Med Sci. 2012;67(6):698–704. doi:10.1093/gerona/glr233
   PubMed Web of Science ®Google Scholar
• Marroquín EC, Iglesia NM, Cobos LP. Adecuación dela Prescripción Farmaceutica en Personas de 65 Años o más en Centros de salud Docentes de Cáceres. Rev Esp Salud Pública. 2012;86(4):419–434. doi:10.4321/S1135-57272012000400009
   Google Scholar
• Bradley MC, Fahey T, Cahir C, et al. Potentially inappropriate prescribing and cost outcomes for older people: a cross-sectional study using the Northern Ireland Enhanced Prescribing Database. Eur J Clin Pharmacol. 2012;68(10):1425–1433. doi:10.1007/s00228-012-1249-y
   PubMed Web of Science ®Google Scholar
• Delgado Silveira E, Garcia M, Montero-Errasquin B, Cruz-Jentoft AJ, Gallagher PF, Sachez Castelhano C. Inappropriate prescription in older patients: the STOPP/START criteria. Rev Esp Geriatr Gerontol. 2009;44(5):273–279. doi:10.1016/j.regg.2009.03.017
   PubMedGoogle Scholar
• Cahir C, Fahey T, Teeling M, Teljeur C, Feely J, Bennett K. Potentially inappropriate prescribing and cost outcomes for older people: a national population study. BJCP. 2010;69(5):543–552. doi:10.1111/j.1365-2125.2010.03628.x
   Web of Science ®Google Scholar
• Hyttinen V, Jyrkka J, Valtonen H. A systematic review of the impact of potentially inappropriate medication on health care utilization and costs among older adults. Med Care. 2016;54(10):950–964. doi:10.1097/MLR.0000000000000587
   PubMed Web of Science ®Google Scholar
• Heider D, Matschinger H, Meid AD, et al. The impact of potentially inappropriate medication on the development of health care costs and its moderation by the number of prescribed substances. Results of a retrospective matched cohort study. PLoS One. 2018:1–12. doi:10.1371/journal.pone.0198004.
   Web of Science ®Google Scholar
• Spinewine A, Schmader KE, Barber N, et al. Appropriate prescribing in elderly people: how well can it be measured and optimised? Lancet. 2007;370(9582):173–184. doi:10.1016/S0140-6736(07)61091-5
   PubMed Web of Science ®Google Scholar
• Kara Ö, Arık G, Kızılarslanoglu MC, et al. Potentially inappropriate prescribing according to the STOPP/START criteria for older adults. Aging Clin Exp Res. 2016;28(4):761–768. doi:10.1007/s40520-015-0475-4
   Web of Science ®Google Scholar
• Kuijpers MAJ, Van Marum RJ, Egberts ACG, Jansen PAF, Oldy T. Relationship between polypharmacy and underprescribing. BJCP. 2007;65(1):130–133. doi:10.1046/j.0306-5251.2007.02961.x
   Google Scholar
• Muhlack DC, Hoppe LK, Weberpals J, Brenner H, Schöttker B. The association of potentially inappropriate medication at older age with cardiovascular events and overall mortality: a systematic review and meta-analysis of cohort studies. J Am Med Dir Assoc. 2017;18(3):211–220. doi:10.1016/j.jamda.2016.11.025
   PubMed Web of Science ®Google Scholar
• Road W, House TB, Trust F, Yorkshire W. Best practice guidelines for the management of frailty: a British Geriatrics Society, Age UK and Royal College of General Practitioners report. Age Ageing. 2014;43(6):744–747. doi:10.1093/ageing/afu138
   Web of Science ®Google Scholar
• Gallagher P, Ryan C, Byrne S, Kennedy J, O’Mahony D. STOPP (Screening Tool of Older Person’s Prescriptions) and START (Screening Tool to Alert doctors to Right Treatment). Consensus validation. Int J Clin Pharmacol Ther. 2008;46(2):72–83. doi:10.5414/cpp46072
   PubMed Web of Science ®Google Scholar
• O´Mahony D, O´Sullivan D, Byrne S, O´Connor MN, Ryan C, Gallagher P. STOPP/START criteria for potentially inappropriate prescribing in older people: version 2. Age Ageing. 2014;1–6. doi:10.1093/ageing/afu145
   Web of Science ®Google Scholar
• Naveiro-Rilo JC, Diez-Juárez D, Flores-Zurutuza ML, Molina-Mazo R, Alberte-Pérez C. Intervencion en ancianos con multimorbilidad y polimedicados: resultados en la prescripcio n y en la calidad de vida. Rev Calid Asist. 2014;29(5):256–262. doi:10.1016/j.cali.2014.06.002
   Google Scholar
• Dalleur O, Boland B, Losseau C, et al. Reduction of potentially inappropriate medications using the STOPP criteria in frail older inpatients: a randomised controlled study. Drugs Aging. 2014;31(4):291–298. doi:10.1007/s40266-014-0157-5
   PubMed Web of Science ®Google Scholar
• Unutmaz GD, Soysal P, Tuven B, Isik AT. Costs of medication in older patients: before and after comprehensive geriatric assessment. Clin Interv Aging. 2018;13:607–613. doi:10.2147/CIA.S159966
   PubMed Web of Science ®Google Scholar
• Hill-Taylor B, Walsh KA, Stewart S, Hayden J, Byrne S, Sketris IS. Effectiveness of the STOPP/START (Screening Tool of Older Persons’ potentially inappropriate Prescriptions/Screening Tool to Alert doctors to the Right Treatment) criteria: systematic review and meta-analysis of randomized controlled studies. J Clin Pharm Ther. 2016;41(2):158–169. doi:10.1111/jcpt.12372
   PubMed Web of Science ®Google Scholar
• Gillespie U, Alassaad A, Hammarlund-Udenaes M, et al. Effects of pharmacists ’ interventions on appropriateness of prescribing and evaluation of the instruments ’ (MAI, STOPP and STARTs ’) ability to predict hospitalization — analyses from a randomized controlled trial. PLoS One. 2013;8:5. doi:10.1371/journal.pone.0062401
   Web of Science ®Google Scholar
• Sullivan DO, Mahony DO, Connor MNO, et al. The impact of a structured pharmacist intervention on the appropriateness of prescribing in older hospitalized patients. Drugs Aging. 2014;31:471–481. doi:10.1007/s40266-014-0172-6
   Web of Science ®Google Scholar
• Samuel MJ. American Geriatrics Society 2015 updated beers criteria for potentially inappropriate medication use in older adults. J Am Geriatr Soc. 2015;63(11):2227–2246. doi:10.1111/jgs.13702
   PubMed Web of Science ®Google Scholar
• Salbu RL, Feuer J. A closer look at the 2015 Beers Criteria. J Pharm Pract. 2017;30(4):419–424. doi:10.1177/0897190016663072
   Google Scholar
• Steinman MA, Beizer JL, Dubeau CE, Laird RD, Lundebjerg NE, Mulhausen P. How to use the American Geriatrics Society 2015 Beers Criteria - a guide for patients, clinicians, health systems, and payors. J Am Geriatr Soc. 2015;63(11):e1–7. doi:10.1111/jgs.13701
   Web of Science ®Google Scholar
• Renom-Guiteras A, Meyer G, Thürmann PA. The EU(7)-PIM list: a list of potentially inappropriate medications for older people consented by experts from seven European countries. Eur J Clin Pharmacol. 2015;71(7):861–875. doi:10.1007/s00228-015-1860-9
   PubMed Web of Science ®Google Scholar
• de Oliveira Martins S, Soares MA, Foppe Van Mil JW, Cabrita J. Inappropriate drug use by Portuguese elderly outpatients - Effect of the Beers criteria update. Pharm World Sci. 2006;28(5):296–301. doi:10.1007/s11096-006-9046-2
   Google Scholar
• da Costa FA, Periquito C, Carneiro MC, Oliveira P, Fernandes AI, Cavaco-Silva P. Potentially inappropriate medications in a sample of Portuguese nursing home residents: does the choice of screening tools matter? Int J Clin Pharm. 2016;38(5):1103–1111. doi:10.1007/s11096-016-0337-y
   PubMed Web of Science ®Google Scholar
• Silva C, Ramalho C, Luz I, Monteiro J, Fresco P. Drug-related problems in institutionalized, polymedicated elderly patients: opportunities for pharmacist intervention. Int J Clin Pharmacol. 2015;37:327–334. doi:10.1007/s11096-014-0063-2
   Web of Science ®Google Scholar
• Ravera S, Hummel SA, Stolk P, Heerdink RE, de Gier J. The use of driving impairing medicines: a European survey. Eur J Clin Pharmacol. 2009;65:1139–1147. doi:10.1007/s00228-009-0695-7
   Web of Science ®Google Scholar
• Huang AR, Mallet L, Rochefort CM, Eguale T, Buckeridge D, Tamblyn R. Medication-related falls in the elderly: causative factors and preventive strategies. Drugs Aging. 2012;29(5):359–376. doi:10.2165/11599460-000000000-00000
   PubMed Web of Science ®Google Scholar
• Toepfer S, Bolbrinker J, Konig M, Steinhagen-Thiessen E, Kreutz R, Demuth I. Potentially inappropriate medication in older participants of the Berlin Aging Study II (BASE- II) – sex differences and associations with morbidity and medication use. PLoS One. 2019;14(12):1–12. doi:10.1371/journal.pone.0226511
   Web of Science ®Google Scholar
• Pretorius RW, Gataric G, Swedlund SK, Miller JR. Reducing the risk of adverse drug events in older adults. Am Fam Physician. 2013;87(5):331–336.
   PubMed Web of Science ®Google Scholar
• Brunetti E, Aurucci ML, Boietti E, et al. Clinical implications of potentially inappropriate prescribing according to STOPP/START version 2 criteria in older polymorbid patients discharged from geriatric and internal medicine wards: a prospective observational multicenter study. J Am Med Dir Assoc. 2019;20(11):1476.e1-1476.e10. doi:10.1016/j.jamda.2019.03.023
   Web of Science ®Google Scholar
• Paci J, Alfaro M, Alonso F, San- Martín M. Prescripción inadecuada en pacientes polimedicados mayores de 64 años en atención primaria. Aten Primaria. 2015;47(1):38–47. doi:10.1016/j.aprim.2014.03.013
   Web of Science ®Google Scholar
• Stojanović M, Vuković M, Dimitrijević S. GheOP 3 S tool and START/STOPP criteria version 2 for screening of potentially inappropriate medications and omissions in nursing home residents. J Eval Clin Pract. 2020;26:158–164. doi:10.1111/jep.13107
   PubMed Web of Science ®Google Scholar
• Mucalo I, Hadžiabdić MO, Brajković A, et al. Potentially inappropriate medicines in elderly hospitalised patients according to the EU(7)-PIM list, STOPP version 2 criteria and comprehensive protocol. Eur J Clin Pharmacol. 2017;73(8):991–999. doi:10.1007/s00228-017-2246-y
   Web of Science ®Google Scholar
• Grina D, Briedis V. The use of potentially inappropriate medications among the Lithuanian elderly according to Beers and EU(7)-PIM list – a nationwide cross-sectional study on reimbursement claims data. J Clin Pharm Ther. 2017;42(2):195–200. doi:10.1111/jcpt.12494
   Web of Science ®Google Scholar
• Stojanovic M, Vukovic M, Jovanovic M, Dimitrijevic S, Radenkovic M. Potentially inappropriate medications in nursing home residents: a comparison of two approaches. Eval Heal Prof. 2020;22:1–6. doi:10.1177/0163278719900653
   Web of Science ®Google Scholar
• Gleeson H, Hafford-letchfield T, Quaife M, et al. Preventing and responding to depression, self- harm, and suicide in older people living in long term care settings: a systematic review. Aging Ment Health. 2019;23(11):1467–1477. doi:10.1080/13607863.2018.1501666
   PubMed Web of Science ®Google Scholar
• Infarmed. Comunicado de imprensa 1/1 inibidores da bomba de protões (IBP) campanha visa alertar para os riscos dos medicamentos para a acidez do estômago[press release 1/1 proton pump inhibitors (IBP) visa warning campaign for risks of drugs for stomach acidity]. Available from: http://www.infarmed.pt/documents/15786/1879176/Comunicado+-+Campanha+IBP/bb11fdf6-cb41-408a-a186-99bca397fc46. Acessed August 21, 2018. Portuguese.
   Google Scholar
• Dalleur O, Spinewine A, Henrard S, Losseau C, Speybroeck N, Boland B. Inappropriate prescribing and related hospital admissions in frail older persons according to the STOPP and START criteria. Drugs Aging. 2012;29(10):829–837. doi:10.1007/s40266-012-0016-1
   PubMed Web of Science ®Google Scholar
• Barry PJ, Gallagher P, Ryan C, O’Mahony D. START (screening tool to alert doctors to the right treatment)— an evidence-based screening tool to detect prescribing omissions in elderly. Age Ageing. 2007;36:632–638. doi:10.1093/ageing/afm118
   PubMed Web of Science ®Google Scholar
• DGS. Guidance no 018/2017, 26 September 2017, Available from: https://www.dgs.pt/paginas-de-sistema/saude-de-a-a-z/gripe/normas-e-orientacoes.aspx. Acessed August 21, 2018.
   Google Scholar
• Golomb BA, Chan VT, Evans MA, Koperski S, White HL, Criqui MH. The older the better: are elderly study participants more non-representative? A cross-sectional analysis of clinical trial and observational study samples. BMJ Open. 2012;2:6. doi:10.1136/bmjopen-2012-000833
   Web of Science ®Google Scholar